RE-implantation of CYpher stent for Cypher in-Lesion restenosis

RE-implantation of CYpher stent for Cypher in-Lesion restenosis - RECYCLE trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005038

Enrollment

100

Registered

2011-02-14

Start date

2008-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic heart disease

Interventions

POBA SES

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with SES restenosis

Exclusion criteria

Exclusion criteria: Post resuscitation Cardiogenic shock ST elevation myocardial infarction Unprotected Left main didesease Patients who cannot torelate anti-platelet therapy Pregnancy or lactation Patients who were enrolled in the other trials Malignancy No indication for PCI

Design outcomes

Primary

Measure	Time frame
late loss at 8-month follow-up angiography	—

Secondary

Measure	Time frame
1) restenosis rate 2) Target lesion revasclurarization at 8-month, 12-month 3) Major adverse cardiac events at 8-month, 12-month 4) stent thrombosis at 8-month, 12-month 5) impact of restenotic pattern such as fracture, gap, and edge restenosis on late loss	—

Countries

Japan

Contacts

Public ContactNaomi Yamaguchi

Coronary Intervention Trial & Evaluation (CITE) group Department of Cardiology, Teikyo University

n-yama@med.teikyo-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026